DOCS Share Price Performance
US$0
-53.77 (-100.00%)
Price US$0
Fair ValueUS$37.77
Share Pricen/a
Seeking Alpha • May 15
Doximity, Inc. Stock Price
- 3 Narratives written by author
- 1 Comments on narratives written by author
- 92 Fair Values set on narratives written by author
DOCS Community Narratives
AN
Fair Value
·Fair Value US$37.77 49.0% undervalued intrinsic discount
DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks
1users have liked this narrative
1users have commented on this narrative
41users have followed this narrative
AN
Fair Value
·Fair Value US$25 23.0% undervalued intrinsic discount
Privacy Rules Will Squeeze Margins While Tools Will Support Recovery
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value
·Fair Value US$55 65.0% undervalued intrinsic discount
Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration
Key Takeaways Expansion of workflow modules and AI tools is driving platform growth, increasing user engagement, and bolstering high-margin SaaS opportunities. Strong industry tailwinds and leading clinician network position the company for sustained market share gains and recurring, higher-margin revenue streams.Read more
AN
US$55
65.0% undervalued intrinsic discount
Fair Value
Revenue
8.72% p.a.
Profit Margin
32.03%
Future PE
46.19x
Price in 2029
US$69.03
DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks
Key Takeaways AI-powered workflow tools and high platform engagement drive deeper customer retention, higher revenue per user, and expanding long-term margins. Broad client demand and digital marketing trends position Doximity for sustained growth, improved sales efficiency, and earnings stability through diversified revenue streams.Read more
AN
US$37.77
49.0% undervalued intrinsic discount
Fair Value
Revenue
7.04% p.a.
Profit Margin
31.89%
Future PE
33.61x
Price in 2029
US$47.73
Privacy Rules Will Squeeze Margins While Tools Will Support Recovery
Key Takeaways Rising compliance costs, platform fatigue, and stronger competition may compress margins and threaten Doximity's core revenue growth. Shifts in client digital marketing budgets and the move to integrated health IT platforms could increase customer churn and limit user expansion.Read more
AN
US$25
23.0% undervalued intrinsic discount
Fair Value
Revenue
7.13% p.a.
Profit Margin
27.36%
Future PE
25.9x
Price in 2029
US$31.64
Trending Discussion
Recently Updated Narratives
AN
DOCS: AI Suite And Platform Stickiness Will Support Higher Future Earnings Power
Fair Value: US$55 65.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
DOCS: Healthcare Moat And AI Tools Will Support Future Engagement
Fair Value: US$37.77 49.0% undervalued intrinsic discount
41 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
AN
DOCS: AI Tools And Buybacks Will Shape A Cautious Balanced Outlook
Fair Value: US$25 23.0% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Doximity, Inc. Key Details
About DOCS
- Founded
- 2010
- Employees
- 830
- CEO
- WebsiteView website
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
